A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report

Background: At the outset of the COVID-19 pandemic, there was no routine comprehensive hospital medicines data from the UK available to researchers. These records can be important for many analyses including the effect of certain medicines on the risk of severe COVID-19 outcomes. With the approval o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowan, Anna, Bates, Chris, Hulme, William, Evans, David, Davy, Simon, A Kennedy, Nicholas, Galloway, James, E Mansfield, Kathryn, Bechman, Katie, Matthewman, Julian, Yates, Mark, Brown, Jeremy, Schultze, Anna, Norton, Sam, J. Walker, Alex, E. Morton, Caroline, Bhaskaran, Krishnan, T. Rentsch, Christopher, Williamson, Elizabeth, Croker, Richard, Bacon, Seb, Hickman, George, Ward, Tom, Green, Amelia, Fisher, Louis, J Curtis, Helen, Tazare, John, M. Eggo, Rosalind, Inglesby, Peter, Cockburn, Jonathan, I. McDonald, Helen, Mathur, Rohini, YS Wong, Angel, Forbes, Harriet, Parry, John, Hester, Frank, Harper, Sam, J Douglas, Ian, Smeeth, Liam, A Tomlinson, Laurie, W Lees, Charlie, Evans, Stephen, Smith, Catherine, M. Langan, Sinéad, Mehkar, Amir, MacKenna, Brian, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Data Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120928/
https://www.ncbi.nlm.nih.gov/pubmed/35634533
http://dx.doi.org/10.12688/wellcomeopenres.17360.1

Ejemplares similares

Ejemplares similares